Direct costs in diabetic and non diabetic people: The population-based Turin study, Italy

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 8, 2012, Pages 684-690

  Bruno, G ^a   Picariello, R ^b   Petrelli, A ^b   Panero, F ^a   Costa, G ^c   Cavallo Perin, P ^a   Demaria, M ^d   Gnavi, R ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b ASL TO3   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Regional Environmental Protection Agency of Piedmont   (Italy)

Author keywords

Cost of illness; Costs; Drugs; Economics; Health expenditures; Survey

Indexed keywords

EID: 84864042205     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.04.007     Document Type: Article

References (26)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Espelt A., Borrell C., Roskam A.J., Rodríguez-Sanz M., Stirbu I., Dalmau-Bueno A., et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia 2008, 51:1971-1979.
3. Gnavi R., Karaghiosoff L., Costa G., Merletti F., Bruno G. Socio-economic differences in the prevalence of diabetes: a population study based on administrative data sources. Nutr Metab Cardiovasc Dis 2008, 18:678-682.
4. Gregg E.W., Albright A.L. The public health response to diabetes. Two steps forward, one step back. JAMA 2009, 301:1596-1598.
5. Kahn R., Anderson J.E. Improving diabetes care: the model for health care reform. Diabetes Care 2009, 32:1115-1118.
6. Wilson J.F. Can disease prevention Save health reform?. Ann Int Med 2009, 151:145-148.
7. Economic costs of diabetes in the U.S. in. Diabetes Care 2007, 2008(31):596-615. American Diabetes Association.
8. Oglesby A.K., Secnik K., Barron J., Al-Zakwani I., Lage M.J. The association between diabetes related medical costs and glycemic control: a retrospective analysis. Cost Effectiveness and Resource Allocation 2006, 16:4-11.
9. Brandle M., Zhou H., Smith B.R., Marriott D., Burke R., Tabaei B.P., et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003, 26:2300-2304.
10. Dawson K.G., Gomes D., Gerstein H., Blanchard J.F., Kahler K.H. The economic cost of diabetes in Canada. Diabetes Care 1998, 2002(25):1303-1307.
11. Knuiman M.W., Davis W.A., Hendrie D., Davis T.M.E. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes. The Fremantle Diabetes Study. Diabetes Care 2005, 28:329-336.
12. Jönsson B. CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia 2002, 45:S5-12.
13. Henriksson F., Agardh C.D., Berne C., Bolinder J., Lönnqvist F., Stenström P., et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000, 248:387-396.
14. Oliva J., Lobo F., Molina B., Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004, 27:2616-2621.
15. Koster I., von Ferber L., Ihle P., Schubert I., Hauner H. The cost burden of diabetes mellitus: the evidence from Germany. The CoDiM study. Diabetologia 2006, 49:1498-1504.
16. Bruno G., Karaghiosoff L., Merletti F., Costa G., De Maria M., Panero F., et al. The impact of diabetes on prescription drug costs: the population-based Turin Study. Diabetologia 2008, 51:795-801.
17. Gnavi R., Picariello R., Karaghiosoff L., Costa G., Giorda C. Determinants of quality in diabetes care process: the population based Torino study. Diabetes Care 2009, 32:1986-1992.
18. Mihaylova B., Briggs A., O'Hagan A., Thompson S.G. Review of statistical methods for analysing healthcare resources and costs. Health Econ 2010, 10.1002/hec.
19. Bruno G., Novelli G., Panero F., Perotto M., Monasterolo F., Bona G., et al. Group for Diabetes Epidemiology. Incidence of type 1 diabetes is increasing both in children and young adults in Northern Italy: 1984-2004 temporal trend. Diabetologia 2009, 52:2531-2535.
20. Bruno G., Merletti F., Bargero G., Melis D., Masi I., Ianni A., et al. Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato Surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 2008, 18:39-45.
21. (accessed 26.03.11). http://www.agenas.it/agenas_pdf/evoluzione_spesa_01-05.pdf.
22. Colagiuri S., Borch-Johnsen K., Glümer C., Vistisen D. There really is an epidemic of type 2 diabetes?. Diabetologia 2005, 48:1459-1463.
23. Marchesini G., Forlani G., Rossi E., Berti A., De Rosa M. The ARNO Working Group. The direct economic cost of pharmacologically-treated diabetes in Italy, 2006 ARNO Observatory. Nutr Metab Cardiovasc Dis 2011, 21(5):339-346.
24. Evans J.M., Barnett K.N., Ogston S.A., Morris A.D. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?. Diabetologia 2007, 50:729-732.
25. Jagger C., Gillies C., Moscone F., Cambois E., Van Oyen H., Nusselder W., et al. EHLEIS team. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. Lancet 2008, 20:2124-2131.
26. Giorda C., Petrelli A., Gnavi R. Regional Board for Diabetes Care of Piemonte. The impact of second-level specialized care on hospitalization in persons with diabetes: a multilevel population-based study. Diabet Med 2006, 23:377-383.